Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Investor Relations

CYTH Articles Cyclo Therapeutics Inc.

home / stock / cyth / cyth articles

CYTH CYTH Quote CYTH Short CYTH News CYTH Articles CYTH Message Board

Articles | Cyclo Therapeutics Inc. (NASDAQ:CYTH)

  • Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

    Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase pro...

    • December 28, 2023 06:07:18 pm
    • |
    • Benzinga
    • |
      • CYTH Stock
      • CYTH Quote
      • CYTH Short
      • CYTH News
      • CYTH Articles
      • CYTH Message Board
  • Why Bridgeline Digital Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket | Benzinga

    Shares of Bridgeline Digital, Inc. (NASDAQ: BLIN) fell sharply in pre-market following the release of fourth-quarter results. Bridgeline Digital p...

    • December 28, 2023 01:22:02 pm
    • |
    • Benzinga
    • |
      • CYTH Stock
      • CYTH Quote
      • CYTH Short
      • CYTH News
      • CYTH Articles
      • CYTH Message Board
  • SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPLK, CYTH, AMTI | Benzinga

    NEW YORK, Sept. 23, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potenti...

    • September 24, 2023 02:29:06 am
    • |
    • Benzinga
    • |
      • CYTH Stock
      • CYTH Quote
      • CYTH Short
      • CYTH News
      • CYTH Articles
      • CYTH Message Board
  • Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

    Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. Near Intelligence, Inc. (NASDAQ: NIR) g...

    • September 21, 2023 05:16:52 pm
    • |
    • Benzinga
    • |
      • CYTH Stock
      • CYTH Quote
      • CYTH Short
      • CYTH News
      • CYTH Articles
      • CYTH Message Board
  • Rare Disease Player Cyclo Therapeutics To Merge With Applied Molecular Transport | Benzinga

    Applied Molecular Transport Inc (NASDAQ: AMTI) has agreed to merge with Cyclo Therapeutics Inc (NASDAQ: CYTH) in an all-stock t...

    • September 21, 2023 01:46:28 pm
    • |
    • Benzinga
    • |
      • CYTH Stock
      • CYTH Quote
      • CYTH Short
      • CYTH News
      • CYTH Articles
      • CYTH Message Board
Stock Information
Get CYTH Alerts

News, Short Squeeze, Breakout and More Instantly...

Cyclo Therapeutics Inc. Company Name:

CYTH Stock Symbol:

NASDAQ Market:

-1.03% G/L:

$0.70 Last:

35,265 Volume:

$0.687 Open:

$0.70 Close:

Cyclo Therapeutics Inc. Website:

Cyclo Therapeutics Inc. Logo

Ad

Investor Relations
RECENT CYTH NEWS
  • CYTH - Expected US Company Earnings on Monday, March 17th, 2025

    Eyenovia Inc. (EYEN) is expected to report $-8 for Q4 2024 Nemaura Medical Inc. (NMRD) is expected to report for quarter end 2024-12-31 LanzaTech Global Inc. (LNZA) is expected to report $-0.16 for Q4 2024 Investcorp Credit Management BDC Inc. (ICMB) is expected to report for Q2 2025 ...

  • CYTH - Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results

    The planned merger with Cyclo Therapeutics is anticipated to close in Q3 pending shareholder approvals Post-merger the Company intends to focus its efforts on Cyclo’s lead clinical program Trappsol ® Cyclo™ NEWARK, N.J., March 13, 2025 (GLOBE NEWSW...

  • CYTH - Cyclo Therapeutics Presents Positive Preliminary Phase 3 Data from Ongoing TransportNPC Open-Label Sub-Study

    2025-02-07 09:23:14 ET DENVER, Colo., Feb 07, 2025 ( 247marketnews.com )- Cyclo Therapeutics (NASDAQ: CYTH ) reportedly made significant progress in its ongoing Phase 3 TransportNPC study. The study is evaluating Trappsol Cyclo for the treatment of Niemann-Pick Disease Type C1 (NPC1...

  •
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.

Trending Stock Alerts

Trending Stock Alerts

Our Next Stock Alert could be Coming in Minutes!

Sign Up Today To Get Full Access To Our Next Stock Report!

  • Day Before Email and Text Notifications of New Alerts
  • Day of Email and Text Notifications
  • Trending Stocks, Watchlist and News Releases
  • Mobile App Notifications
Trending Stock Alerts

Get CYTH Alerts

Get CYTH Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.

Forgot password?


Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord

Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1